ARTICLE | Company News
Novartis, Oryx CNS deal
September 3, 2002 7:00 AM UTC
Specialty pharma company Oryx Pharmaceuticals (Mississauga, Ontario) acquired Canadian rights to Anafranil clomipramine from Novartis (NVS; SWX:NOVN) to treat depression and obsessive compulsive disea...